Clinical Trial Update: Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating pembrolizumab for progressive multifocal leukoencephalopathy in immunocompromised patients without HIV infection is in Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Progressive Multifocal Leukoencephalopathy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING